FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052667900> ?p ?o ?g. }

• W2052667900 endingPage "383" @default.
• W2052667900 startingPage "376" @default.
• W2052667900 abstract "Mycophenolate mofetil (MMF) is now part of standard immunosuppression in the first phase after renal transplantation. A relevant question is if it can replace drugs such as cyclosporine (CsA) in the maintenance treatment, improving cardiovascular risk profile.In 17 patients with a stable renal function (at least 6 months) posttransplantation, we studied the effect of CsA replacement by MMF. After starting MMF (1 g b.i.d.), CsA dosage was reduced from regular to low (median trough level 130 microg/L, respectively, 45 microg/L), followed by complete withdrawal, while prednisone (7.5 mg daily) was continued. We measured ambulatory blood pressure, glomerular filtration rate, renal plasma flow, renal vascular resistance, and metabolic factors at start and after 8 weeks on regular, low-dose CsA, respectively, no CsA with MMF and prednisone.Two patients dropped out after the switch to low-dose CsA/MMF, due to diarrhea in one and a steroid responsive rejection in the other. The complete switch from CsA to MMF was successful in all 15 patients and accompanied by a decrease in 24 hr systolic blood pressure (from 152+/-13 to 145+/-13 mmHg; P<0.01), diastolic blood pressure (93+/-9 to 89+/-12 mmHg; P<0.05), RVR (0.29+/-0.06 to 0.25+/-0.09 mmHg.ml/min; P<0.05), and an increase in glomerular filtration rate (46.6+/-8.8 to 58.0+/-10.5 ml/min; P<0.01) and renal plasma flow. Intermediate low density lipoprotein-cholesterol decreased (0.79+/-0.37 to 0.41+/-0.16 mmol/L; P<0.01). High density lipoprotein-cholesterol decreased, but remained in the safe range. After 1 year two patients stopped the MMF; one because of Kaposi's sarcoma and one because of recurrent infectionsThe stepwise switch from CsA to MMF was safe and mostly successful, and had beneficial effects on blood pressure, glomerular hemodynamics, and lipid profile. Beneficial trends were already present after partial withdrawal of CsA." @default.
• W2052667900 created "2016-06-24" @default.
• W2052667900 creator A5037520101 @default.
• W2052667900 creator A5040512989 @default.
• W2052667900 creator A5058101939 @default.
• W2052667900 creator A5062438369 @default.
• W2052667900 creator A5076010133 @default.
• W2052667900 creator A5086322343 @default.
• W2052667900 date "2000-02-01" @default.
• W2052667900 modified "2023-10-18" @default.
• W2052667900 title "CONVERSION TO MYCOPHENOLATE MOFETIL IN CONJUNCTION WITH STEPWISE WITHDRAWAL OF CYCLOSPORINE IN STABLE RENAL TRANSPLANT RECIPIENTS1" @default.
• W2052667900 cites W1939259427 @default.
• W2052667900 cites W1956431565 @default.
• W2052667900 cites W1960912206 @default.
• W2052667900 cites W1972131580 @default.
• W2052667900 cites W1974051274 @default.
• W2052667900 cites W1975366846 @default.
• W2052667900 cites W1976089771 @default.
• W2052667900 cites W1978868458 @default.
• W2052667900 cites W1979050172 @default.
• W2052667900 cites W1984762252 @default.
• W2052667900 cites W1986397529 @default.
• W2052667900 cites W1988731412 @default.
• W2052667900 cites W1992887494 @default.
• W2052667900 cites W1993413428 @default.
• W2052667900 cites W1998289175 @default.
• W2052667900 cites W1998535208 @default.
• W2052667900 cites W1999226706 @default.
• W2052667900 cites W2004931181 @default.
• W2052667900 cites W2007534048 @default.
• W2052667900 cites W2010608641 @default.
• W2052667900 cites W2018866877 @default.
• W2052667900 cites W2022373786 @default.
• W2052667900 cites W2023754172 @default.
• W2052667900 cites W2033567610 @default.
• W2052667900 cites W2033699712 @default.
• W2052667900 cites W2037460341 @default.
• W2052667900 cites W2041006323 @default.
• W2052667900 cites W2043154979 @default.
• W2052667900 cites W2050892029 @default.
• W2052667900 cites W2051143996 @default.
• W2052667900 cites W2051603643 @default.
• W2052667900 cites W2051795365 @default.
• W2052667900 cites W2052082703 @default.
• W2052667900 cites W2055285204 @default.
• W2052667900 cites W2060864416 @default.
• W2052667900 cites W2061731854 @default.
• W2052667900 cites W2062162902 @default.
• W2052667900 cites W2070791718 @default.
• W2052667900 cites W2082390491 @default.
• W2052667900 cites W2083334531 @default.
• W2052667900 cites W2086060797 @default.
• W2052667900 cites W2086415014 @default.
• W2052667900 cites W2088495365 @default.
• W2052667900 cites W2091197267 @default.
• W2052667900 cites W2093162411 @default.
• W2052667900 cites W2100872766 @default.
• W2052667900 cites W2110733037 @default.
• W2052667900 cites W2120093793 @default.
• W2052667900 cites W2128407483 @default.
• W2052667900 cites W2141251694 @default.
• W2052667900 cites W2149064977 @default.
• W2052667900 cites W2161003745 @default.
• W2052667900 cites W2166648967 @default.
• W2052667900 cites W2324876747 @default.
• W2052667900 cites W2434780703 @default.
• W2052667900 cites W2609602266 @default.
• W2052667900 cites W2715652611 @default.
• W2052667900 cites W4233292045 @default.
• W2052667900 cites W4234702878 @default.
• W2052667900 cites W4236727254 @default.
• W2052667900 cites W4240718512 @default.
• W2052667900 cites W4243985134 @default.
• W2052667900 cites W4252150056 @default.
• W2052667900 cites W4300931874 @default.
• W2052667900 cites W50336179 @default.
• W2052667900 doi "https://doi.org/10.1097/00007890-200002150-00012" @default.
• W2052667900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10706046" @default.
• W2052667900 hasPublicationYear "2000" @default.
• W2052667900 type Work @default.
• W2052667900 sameAs 2052667900 @default.
• W2052667900 citedByCount "64" @default.
• W2052667900 countsByYear W20526679002013 @default.
• W2052667900 countsByYear W20526679002016 @default.
• W2052667900 countsByYear W20526679002017 @default.
• W2052667900 countsByYear W20526679002021 @default.
• W2052667900 crossrefType "journal-article" @default.
• W2052667900 hasAuthorship W2052667900A5037520101 @default.
• W2052667900 hasAuthorship W2052667900A5040512989 @default.
• W2052667900 hasAuthorship W2052667900A5058101939 @default.
• W2052667900 hasAuthorship W2052667900A5062438369 @default.
• W2052667900 hasAuthorship W2052667900A5076010133 @default.
• W2052667900 hasAuthorship W2052667900A5086322343 @default.
• W2052667900 hasBestOaLocation W20526679001 @default.
• W2052667900 hasConcept C126322002 @default.
• W2052667900 hasConcept C126894567 @default.
• W2052667900 hasConcept C134018914 @default.
• W2052667900 hasConcept C142225936 @default.

• next